For the year ending 2025-12-31, JUNS made $21,796 in revenue. -$8,644,897 in net income. Net profit margin of -39662.77%.
| Income Statement | 2025-12-31 | |||
|---|---|---|---|---|
| Product revenues, net | 21,796 | |||
| Cost of goods sold | 4,231 | |||
| Gross profit | 17,565 | |||
| Research and development | 2,086,574 | |||
| General and administrative | 6,839,712 | |||
| Total operating expenses | 8,926,286 | |||
| Operating loss | -8,908,721 | |||
| Gain on change in fair value of convertible notes | 281,932 | |||
| Interest expense | 66,020 | |||
| Other income | 47,912 | |||
| Total other expenses, net | 263,824 | |||
| Net income (loss) | -8,644,897 | |||
| Basic EPS | -0.25 | |||
| Diluted EPS | -0.25 | |||
| Basic Average Shares | 34,628,588 | |||
| Diluted Average Shares | 34,628,588 | |||
JUPITER NEUROSCIENCES, INC. (JUNS)
JUPITER NEUROSCIENCES, INC. (JUNS)